News
Study Finds on MSN42m
Weight Loss Showdown: Mounjaro (Tirzepatide) Trounces Wegovy in Head-to-Head TrialIn a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback